Quantification of RNA editing of the serotonin 2C receptor (5-HT 2C R) ex vivo

Methods in Enzymology

Volumn 485, Issue C, 2010, Pages 311-328

  Lanfranco, Maria Fe ^a   Anastasio, Noelle C ^a   Seitz, Patricia K ^a   Cunningham, Kathryn A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROTRANSMITTER; SEROTONIN 2C RECEPTOR;

ADDICTION; BOOK; DEPRESSION; DNA DETERMINATION; DNA LIBRARY; DNA SEQUENCE; ENZYME SPECIFICITY; IN VITRO STUDY; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EDITING; RNA EXTRACTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 78049489564     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381296-4.00018-X     Document Type: Chapter

References (53)

1. Abbas A.I., Urban D.J., Jensen N.H., Farrell M.S., Kroeze W.K., Mieczkowski P., Wang Z., Roth B.L. Assessing serotonin receptor mRNA editing frequency by a novel ultra high-throughput sequencing method. Nucleic Acids Res 2010, 38(10):1-13.
2. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71:817-846.
3. Bentley D.R., Balasubramanian S., Swerdlow H.P., Smith G.P., Milton J., Brown C.G., Hall K.P., Evers D.J., Barnes C.L., Bignell H.R., Boutell J.M., Bryant J., et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008, 456:53-59.
4. Berg K.A., Cropper J.D., Niswender C.M., Sanders-Bush E., Emeson R.B., Clarke W.P. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br. J. Pharmacol. 2001, 134:386-392.
5. Berg K.A., Dunlop J., Sanchez T., Silva M., Clarke W.P. A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling. J. Pharmacol. Exp. Ther. 2008, 324:1084-1092.
6. Berg K.A., Harvey J.A., Spampinato U., Clarke W.P. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression. Prog. Brain Res. 2008, 172:287-305.
7. 2 R pharmacotherapy in psychostimulant abuse. Prog. Brain Res. 2008, 172:319-346.
8. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., Emeson R.B. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997, 387:303-308.
9. Cruz-Reyes J., Rusche L.N., Piller K.J., Sollner-Webb B. T. brucei RNA editing: Adenosine nucleotides inversely affect U-deletion and U-insertion reactions at mRNA cleavage. Mol. Cell 1998, 1:401-409.
10. De La Vega F.M., Lazaruk K.D., Rhodes M.D., Wenz M.H. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP genotyping assays and the SNPlex genotyping system. Mutat. Res. 2005, 573:111-135.
11. Dracheva S., Elhakem S.L., Marcus S.M., Siever L.J., McGurk S.R., Haroutunian V. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J. Neurochem. 2003, 87:1402-1412.
12. Dracheva S., Chin B., Haroutunian V. Altered serotonin 2C receptor RNA splicing in suicide: Association with editing. Neuroreport 2008, 19:379-382.
13. Dracheva S., Patel N., Woo D.A., Marcus S.M., Siever L.J., Haroutunian V. Increased serotonin 2C receptor mRNA editing: A possible risk factor for suicide. Mol. Psychiatry 2008, 13:1001-1010.
14. Dracheva S., Lyddon R., Barley K., Marcus S.M., Hurd Y.L., Byne W.M. Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral trait. Neuropsychopharmacology 2009, 34:2237-2251.
15. Du Y., Davisson M.T., Kafadar K., Gardiner K. A-to-I pre-mRNA editing of the serotonin 2C receptor: Comparisons among inbred mouse strains. Gene 2006, 382:39-46.
16. Fitzgerald L.W., Iyer G., Conklin D.S., Krause C.M., Marshall A., Patterson J.P., Tran D.P., Jonak G.J., Hartig P.R. Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 1999, 21:82S-90S.
17. Giorgetti M., Tecott L.H. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. Eur. J. Pharmacol. 2004, 488:1-9.
18. Gurevich I., Englander M.T., Adlersberg M., Siegal N.B., Schmauss C. Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J. Neurosci. 2002, 22:10529-10532.
19. Gurevich I., Tamir H., Arango V., Dwork A.J., Mann J.J., Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002, 34:349-356.
20. Hembruff S.L., Villeneuve D.J., Parissenti A.M. The optimization of quantitative reverse transcription PCR for verification of cDNA microarray data. Anal. Biochem. 2005, 345:237-249.
21. Herrick-Davis K., Grinde E., Niswender C.M. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: Implications for serotonergic signal transduction. J. Neurochem. 1999, 73:1711-1717.
22. Herrick-Davis K., Grinde E., Harrigan T.J., Mazurkiewicz J.E. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: Receptor dimers bind two molecules of ligand and one G-protein. J. Biol. Chem. 2005, 280:40144-40151.
23. Hoopengardner B., Bhalla T., Staber C., Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science 2003, 301:832-836.
24. Igo R.P., Weston D.S., Ernst N.L., Panigrahi A.K., Salavati R., Stuart K. Role of uridylate-specific exoribonuclease activity in Trypanosoma brucei RNA editing. Eukaryot. Cell 2002, 1:112-118.
25. Iwamoto K., Bundo M., Kato T. Estimating RNA editing efficiency of five editing sites in the serotonin 2C receptor by pyrosequencing. RNA 2005, 11:1596-1603.
26. Iwamoto K., Nakatani N., Bundo M., Yoshikawa T., Kato T. Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci. Res. 2005, 53:69-76.
27. Julius D., MacDermott A.B., Axel R., Jessell J.M. Molecular characterization of a functional cDNA encoding the serotonin 1C receptor. Science 1988, 241:558-564.
28. Julius D., Livelli T.J., Jessell T., Axel R. Ectopic expression of the serotonin 1C receptor and the triggering of malignant transformation. Science 1989, 244:1057-1062.
29. Kaye W.H., Frank G.K., Bailer U.F., Henry S.E., Meltzer C.C., Price J.C., Mathis C.A., Wagner A. Serotonin alterations in anorexia and bulimia nervosa: New insights from imaging studies. Physiol. Behav. 2005, 85:73-81.
30. Kutyavin I.V., Afonina I.A., Mills A., Gorn V.V., Lukhtanov E.A., Belousov E.S., Singer M.J., Walburger D.K., Lokhov S.G., Gall A.A., Dempcy R., Reed M.W., et al. 3'-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 2000, 28:655-661.
31. Lanfranco M.F., Seitz P.K., Morabito M.V., Emeson R.B., Sanders-Bush E., Cunningham K.A. An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT(2C)R) in brain. J. Neurosci. Methods 2009, 179:247-257.
32. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
33. Marion S., Weiner D.M., Caron M.G. RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J. Biol. Chem. 2004, 279:2945-2954.
34. Maydanovych O., Beal P.A. Breaking the central dogma by RNA editing. Chem. Rev. 2006, 106:3397-3411.
35. Morabito M.V., Ulbricht R.J., O'Neil R.T., Airey D.C., Lu P., Zhang B., Wang L., Emeson R.B. High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Mol. Pharmacol. 2010, 77:895-902.
36. Niswender C.M., Sanders-Bush E., Emeson R.B. Identification and characterization of RNA editing events within the 5-HT2C receptor. Ann. NY Acad. Sci. 1998, 861:38-48.
37. Niswender C.M., Copeland S.C., Herrick-Davis K., Emeson R.B., Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J. Biol. Chem. 1999, 274:9472-9478.
38. Niswender C.M., Herrick-Davis K., Dilley G.E., Meltzer H.Y., Overholser J.C., Stockmeier C.A., Emeson R.B., Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 2001, 24:478-491.
39. Poyau A., Vincent L., Berthomme H., Paul C., Nicolas B., Pujol J.F., Madjar J.J. Identification and relative quantification of adenosine to inosine editing in serotonin 2c receptor mRNA by CE. Electrophoresis 2007, 28:2843-2852.
40. Roth B.L., Willins D.L., Kristiansen K., Kroeze W.K. 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): Where structure meets function. Pharmacol. Ther. 1998, 79:231-257.
41. Samuel C.E. RNA editing minireview series. J. Biol. Chem. 2003, 278:1389-1390.
42. Sanders-Bush E., Fentress H., Hazelwood L. Serotonin 5-HT2 receptors: Molecular and genomic diversity. Mol. Interv. 2003, 3:319-330.
43. Schefe J.H., Lehmann K.E., Buschmann I.R., Unger T., Funke-Kaiser H. Quantitative real-time RT-PCR data analysis: Current concepts and the novel "gene expression's CT difference" formula. J. Mol. Med. 2006, 84:901-910.
44. Schmauss C. Serotonin 2C receptors: Suicide, serotonin, and runaway RNA editing. Neuroscientist 2003, 9:237-242.
45. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
46. Serretti A., Artioli P., De R.D. The 5-HT2C receptor as a target for mood disorders. Expert Opin. Ther. Targets 2004, 8:15-23.
47. Sodhi M.S.K., Airey D.C., Lambert W., Burnet P.W.J., Harrison P.J., Sanders-Bush E. A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Mol. Pharmacol. 2005, 68:711-719.
48. Wang Q., O'Brien P.J., Chen C.X., Cho D.S., Murray J.M., Nishikura K. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J. Neurochem. 2000, 74:1290-1300.
49. Werry T.D., Loiacono R., Sexton P.M., Christopoulos A. RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol. Ther. 2008, 119:7-23.
50. Werry T.D., Stewart G.D., Crouch M.F., Watts A., Sexton P.M., Christopoulos A. Pharmacology of 5HT(2C) receptor-mediated ERK1/2 phosphorylation: Agonist-specific activation pathways and the impact of RNA editing. Biochem. Pharmacol. 2008, 76:1276-1287.
51. Wess J. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol. Ther. 1998, 80:231-264.
52. Wong M.L., Medrano J.F. Real-time PCR for mRNA quantitation. Biotechniques 2005, 39:75-85.
53. Yao Y., Nellaker C., Karlsson H. Evaluation of minor groove binding probe and Taqman probe PCR assays: Influence of mismatches and template complexity on quantification. Mol. Cell Probes 2006, 20(5):311-316.